China Red Eye Study (CRES)

April 11, 2020 updated by: Xiaofeng Lin, Sun Yat-sen University
This study intends to use a hospital-based multi-center cross-sectional study to understand the disease composition of "red-eye" patients in Chinese ophthalmology clinics. This study will provide important clinical diagnosis and treatment data for common eye diseases in China with "red eye" as the main performance.

Study Overview

Status

Completed

Conditions

Detailed Description

Red eye is a common sign of eye diseases. Eye diseases such as ocular surface inflammation, glaucoma, and uveitis can be expressed as red eyes. The disease with red eye as the main complaint is the most common condition that clinicians need to identify. It is not uncommon to be misdiagnosed and missed clinically. The collection and analysis of the disease composition of the "red eye" in Chinese ophthalmology clinics will help to understand the current status of "red eye" related diseases and provide a systematic and comprehensive clinical basis for the differential diagnosis of red eye.

Study Type

Observational

Enrollment (Actual)

4382

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chengdu, China
        • West China Hospital of Sichuan University
      • Dalian, China
        • Affiliated Zhongshan Hospital of Dalian University
      • Kunming, China
        • First Affiliated Hospital of Kunming Medical University and Hainan Eye Hospital
      • Nanning, China
        • Nanxishan Hospital of Guangxi Zhuang Autonomous Region
      • Shanghai, China
        • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
      • Wuhan, China
        • llege of Huazhong University of Science and Technology
      • Xinjiang, China
        • The first affiliated hospital of Xinjiang medical university
    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Zhongshan Ophthalmic Center of Sun yat-sen Universtiy
    • Hainan
      • Haikou, Hainan, China
        • Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with "red eye".

Description

Inclusion Criteria:

  • Confirmation of signs under the slit lamp is red eye

Exclusion Criteria:

  • The investigator believes that there are any unsuitable reasons for participating in the trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
medical diagnosis of each patient
Time Frame: 1 day (when the patient come the the doctor)
the investigators record patients' diagnosis on questionnaire when the patient come to the doctor
1 day (when the patient come the the doctor)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

November 8, 2018

First Submitted That Met QC Criteria

January 23, 2019

First Posted (Actual)

January 24, 2019

Study Record Updates

Last Update Posted (Actual)

April 14, 2020

Last Update Submitted That Met QC Criteria

April 11, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • ZOC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Red Eye

3
Subscribe